Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells
Author(s): Cheng M | Xu H | Wang Y | Chen H | He B | Gao X | Li Y | Han J | Zhang Z
Volume: 2013
Issue: default
Year: 2013
Author(s): Cheng M | Xu H | Wang Y | Chen H | He B | Gao X | Li Y | Han J | Zhang Z Volume: 2013 Issue: default Year: 2013
Advances in the proteomic discovery of novel therapeutic targets in cancer
Author(s): Guo S | Zou J | Wang G
Volume: 2013
Issue: default
Year: 2013
Author(s): Guo S | Zou J | Wang G Volume: 2013 Issue: default Year: 2013
Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: effect of a mercaptoacetic acid/N-isopropylacrylamide molar ratio
Author(s): Lai JY
Volume: 2013
Issue: default
Year: 2013
Author(s): Lai JY Volume: 2013 Issue: default Year: 2013
Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
Author(s): Doesch AO | Mueller S | Akyol C | Erbel C | Frankenstein L | Ruhparwar A | Ehlermann P | Dengler TJ | Katus HA
Volume: 2013
Issue: default
Year: 2013
Author(s): Doesch AO | Mueller S | Akyol C | Erbel C | Frankenstein L | Ruhparwar A | Ehlermann P | Dengler TJ | Katus HA Volume: 2013 Issue: default Year: 2013
Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in rats
Author(s): Koga K | Kawamura M | Iwase H | Yoshikawa N
Volume: 2013
Issue: default
Year: 2013
Author(s): Koga K | Kawamura M | Iwase H | Yoshikawa N Volume: 2013 Issue: default Year: 2013
Antioxidant effect of Arabic gum against mercuric chloride-induced nephrotoxicity
Author(s): Gado AM | Aldahmash BA
Volume: 2013
Issue: default
Year: 2013
Author(s): Gado AM | Aldahmash BA Volume: 2013 Issue: default Year: 2013
Current and future G protein-coupled receptor signaling targets for heart failure therapy
Author(s): Siryk-Bathgate A | Dabul S | Lymperopoulos A
Volume: 2013
Issue: default
Year: 2013
Author(s): Siryk-Bathgate A | Dabul S | Lymperopoulos A Volume: 2013 Issue: default Year: 2013
A comparative study of internal laser-assisted and conventional liposuction: a look at the influence of drugs and major surgery on laboratory postoperative values
Author(s): Przylipiak AF | Galicka E | Donejko M | Niczyporuk M | Przylipiak J
Volume: 2013
Issue: default
Year: 2013
Author(s): Przylipiak AF | Galicka E | Donejko M | Niczyporuk M | Przylipiak J Volume: 2013 Issue: default Year: 2013
Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
Author(s): Zhuang H | Yuan Z | Wang J | Zhao L | Pang Q | Wang P
Volume: 2013
Issue: default
Year: 2013
Author(s): Zhuang H | Yuan Z | Wang J | Zhao L | Pang Q | Wang P Volume: 2013 Issue: default Year: 2013
New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
Author(s): Cazzola M | Segreti A | Matera MG
Volume: 2013
Issue: default
Year: 2013
Author(s): Cazzola M | Segreti A | Matera MG Volume: 2013 Issue: default Year: 2013
Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
Author(s): Reardon J | Perumal JS
Volume: 2013
Issue: default
Year: 2013
Author(s): Reardon J | Perumal JS Volume: 2013 Issue: default Year: 2013
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Author(s): Prachayasittikul V | Prachayasittikul S | Ruchirawat S | Prachayasittikul V
Volume: 2013
Issue: default
Year: 2013
Author(s): Prachayasittikul V | Prachayasittikul S | Ruchirawat S | Prachayasittikul V Volume: 2013 Issue: default Year: 2013
Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell lines
Author(s): Zhang M | Drummen GPC | Luo S
Volume: 2013
Issue: default
Year: 2013
Author(s): Zhang M | Drummen GPC | Luo S Volume: 2013 Issue: default Year: 2013
The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes
Author(s): Tsikripis P | Papaconstantinou D | Koutsandrea C | Apostolopoulos M | Georgalas I
Volume: 2013
Issue: default
Year: 2013
Author(s): Tsikripis P | Papaconstantinou D | Koutsandrea C | Apostolopoulos M | Georgalas I Volume: 2013 Issue: default Year: 2013
The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol
Author(s): Poirier S | Mayer G
Volume: 2013
Issue: default
Year: 2013
Author(s): Poirier S | Mayer G Volume: 2013 Issue: default Year: 2013
Clinical experimentation with aerosol antibiotics: current and future methods of administration
Author(s): Zarogoulidis P | Kioumis I | Porpodis K | Spyratos D | Tsakiridis K | Huang H | Li Q | Turner JF | Browning R | Hohenforst-Schmidt W | Zarogoulidis K
Volume: 2013
Issue: default
Year: 2013
Author(s): Zarogoulidis P | Kioumis I | Porpodis K | Spyratos D | Tsakiridis K | Huang H | Li Q | Turner JF | Browning R | Hohenforst-Schmidt W | Zarogoulidis K Volume: 2013 Issue: default Year: 2013
Advances with microRNAs in Parkinson’s disease research
Author(s): Ma L | Wei L | Wu F | Hu Z | Liu Z | Yuan W
Volume: 2013
Issue: default
Year: 2013
Author(s): Ma L | Wei L | Wu F | Hu Z | Liu Z | Yuan W Volume: 2013 Issue: default Year: 2013
A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing
Author(s): Xu TJ | Wang Q | Ma XW | Zhang Z | Zhang W | Xue XC | Zhang C | Hao Q | Li WN | Zhang YQ | Li M
Volume: 2013
Issue: default
Year: 2013
Author(s): Xu TJ | Wang Q | Ma XW | Zhang Z | Zhang W | Xue XC | Zhang C | Hao Q | Li WN | Zhang YQ | Li M Volume: 2013 Issue: default Year: 2013
New structure–activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity
Author(s): Rangel LP | Winter E | Gauthier C | Terreux R | Chiaradia-Delatorre LD | Mascarello A | Nunes RJ | Yunes RA | Creczynski-Pasa TB | Macalou S | Lorendeau D | Baubichon-Cortay H | Ferreira-Pereira A | Di Pietro A
Volume: 2013
Issue: default
Year: 2013
Author(s): Rangel LP | Winter E | Gauthier C | Terreux R | Chiaradia-Delatorre LD | Mascarello A | Nunes RJ | Yunes RA | Creczynski-Pasa TB | Macalou S | Lorendeau D | Baubichon-Cortay H | Ferreira-Pereira A | Di Pietro A Volume: 2013 Issue: default Year: 2013
Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine
Author(s): Maneeton N | Maneeton B | Eurviriyanukul K | Srisurapanont M
Volume: 2013
Issue: default
Year: 2013
Author(s): Maneeton N | Maneeton B | Eurviriyanukul K | Srisurapanont M Volume: 2013 Issue: default Year: 2013
Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization
Author(s): Harsha S
Volume: 2013
Issue: default
Year: 2013
Author(s): Harsha S Volume: 2013 Issue: default Year: 2013
Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures
Author(s): Iannitti T | Rottigni V | Palmieri B
Volume: 2013
Issue: default
Year: 2013
Author(s): Iannitti T | Rottigni V | Palmieri B Volume: 2013 Issue: default Year: 2013
Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
Author(s): Dorniani D | Hussein MZ | Kura AU | Fakurazi S | Shaari AH | Ahmad Z
Volume: 2013
Issue: default
Year: 2013
Author(s): Dorniani D | Hussein MZ | Kura AU | Fakurazi S | Shaari AH | Ahmad Z Volume: 2013 Issue: default Year: 2013
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
Author(s): Capuano A | Sportiello L | Maiorino MI | Rossi F | Giugliano D | Esposito K
Volume: 2013
Issue: default
Year: 2013
Author(s): Capuano A | Sportiello L | Maiorino MI | Rossi F | Giugliano D | Esposito K Volume: 2013 Issue: default Year: 2013
Vitamin D in asthma and future perspectives
Author(s): Huang H | Porpodis K | Zarogoulidis P | Domvri K | Giouleka P | Papaiwannou A | Primikyri S | Mylonaki E | Spyratos D | Hohenforst-Schmidt W | Kioumis I | Zarogoulidis K
Volume: 2013
Issue: default
Year: 2013
Author(s): Huang H | Porpodis K | Zarogoulidis P | Domvri K | Giouleka P | Papaiwannou A | Primikyri S | Mylonaki E | Spyratos D | Hohenforst-Schmidt W | Kioumis I | Zarogoulidis K Volume: 2013 Issue: default Year: 2013
Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux
Author(s): Di Nisio M | Porreca E
Volume: 2013
Issue: default
Year: 2013
Author(s): Di Nisio M | Porreca E Volume: 2013 Issue: default Year: 2013
Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood–brain barrier permeability
Author(s): Oláh G | Herédi J | Menyhárt Á | Czinege Z | Nagy D | Fuzik J | Kocsis K | Knapp L | Krucsó E | Gellért L | Kis Z | Farkas T | Fülöp F | Párdutz Á | Tajti J | Vécsei L | Toldi J
Volume: 2013
Issue: default
Year: 2013
Author(s): Oláh G | Herédi J | Menyhárt Á | Czinege Z | Nagy D | Fuzik J | Kocsis K | Knapp L | Krucsó E | Gellért L | Kis Z | Farkas T | Fülöp F | Párdutz Á | Tajti J | Vécsei L | Toldi J Volume: 2013 Issue: default Year: 2013
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Author(s): Mazo DF | de Oliveira MG | Pereira IV | Cogliati B | Stefano JT | de Souza GF | Rabelo F | Lima FR | Ferreira Alves VA | Carrilho FJ | de Oliveira CP
Volume: 2013
Issue: default
Year: 2013
Author(s): Mazo DF | de Oliveira MG | Pereira IV | Cogliati B | Stefano JT | de Souza GF | Rabelo F | Lima FR | Ferreira Alves VA | Carrilho FJ | de Oliveira CP Volume: 2013 Issue: default Year: 2013
Causes, consequences, and treatment of osteoporosis in men
Author(s): Banu J
Volume: 2013
Issue: default
Year: 2013
Author(s): Banu J Volume: 2013 Issue: default Year: 2013
Clinical study of etomidate emulsion combined with remifentanil in general anesthesia
Author(s): Weng D | Huang M | Jiang R | Zhan R | Yang C
Volume: 2013
Issue: default
Year: 2013
Author(s): Weng D | Huang M | Jiang R | Zhan R | Yang C Volume: 2013 Issue: default Year: 2013
Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions
Author(s): Tjandrawinata RR | Setiawati E | Yunaidi DA | Simanjuntak R | Santoso ID | Susanto LW
Volume: 2013
Issue: default
Year: 2013
Author(s): Tjandrawinata RR | Setiawati E | Yunaidi DA | Simanjuntak R | Santoso ID | Susanto LW Volume: 2013 Issue: default Year: 2013
Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
Author(s): Chao DC | Hu KQ
Volume: 2013
Issue: default
Year: 2013
Author(s): Chao DC | Hu KQ Volume: 2013 Issue: default Year: 2013
In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features
Author(s): Xiang M | Lei K | Fan W | Lin Y | He G | Yang M | Chen L | Mo Y
Volume: 2013
Issue: default
Year: 2013
Author(s): Xiang M | Lei K | Fan W | Lin Y | He G | Yang M | Chen L | Mo Y Volume: 2013 Issue: default Year: 2013
Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review
Author(s): Chen HF | Xu LP | Luo ZY | Yu ZQ | Li ZY | Cui QY | Qin LM | Ren YY | Shen HS | Tang JQ | Jin LJ | Zhu JJ | Wang J | Wang KY | Wu TQ | Wang ZY
Volume: 2013
Issue: default
Year: 2013
Author(s): Chen HF | Xu LP | Luo ZY | Yu ZQ | Li ZY | Cui QY | Qin LM | Ren YY | Shen HS | Tang JQ | Jin LJ | Zhu JJ | Wang J | Wang KY | Wu TQ | Wang ZY Volume: 2013 Issue: default Year: 2013
N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids
Author(s): Grillo SL | Keereetaweep J | Grillo MA | Chapman KD | Koulen P
Volume: 2013
Issue: default
Year: 2013
Author(s): Grillo SL | Keereetaweep J | Grillo MA | Chapman KD | Koulen P Volume: 2013 Issue: default Year: 2013
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
Author(s): Mantovani G | Madeddu C | Maccio A
Volume: 2013
Issue: default
Year: 2013
Author(s): Mantovani G | Madeddu C | Maccio A Volume: 2013 Issue: default Year: 2013
Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
Author(s): Mahe J | Meurette A | Moreau A | Vercel C | Jolliet P
Volume: 2013
Issue: default
Year: 2013
Author(s): Mahe J | Meurette A | Moreau A | Vercel C | Jolliet P Volume: 2013 Issue: default Year: 2013
Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases
Author(s): Allarakhia M
Volume: 2013
Issue: default
Year: 2013
Author(s): Allarakhia M Volume: 2013 Issue: default Year: 2013
Developing therapeutic approaches for metachromatic leukodystrophy
Author(s): Patil SA | Maegawa GHB
Volume: 2013
Issue: default
Year: 2013
Author(s): Patil SA | Maegawa GHB Volume: 2013 Issue: default Year: 2013
Aflibercept in wet AMD: specific role and optimal use
Author(s): Semeraro F | Morescalchi F | Duse S | Parmeggiani F | Gambicorti E | Costagliola C
Volume: 2013
Issue: default
Year: 2013
Author(s): Semeraro F | Morescalchi F | Duse S | Parmeggiani F | Gambicorti E | Costagliola C Volume: 2013 Issue: default Year: 2013
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays
Author(s): Rezende VM | Rivellis A | Novaes MM | Chamone DA | Bendit I
Volume: 2013
Issue: default
Year: 2013
Author(s): Rezende VM | Rivellis A | Novaes MM | Chamone DA | Bendit I Volume: 2013 Issue: default Year: 2013
Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis
Author(s): Jilani JA | Shomaf M | Alzoubi KH
Volume: 2013
Issue: default
Year: 2013
Author(s): Jilani JA | Shomaf M | Alzoubi KH Volume: 2013 Issue: default Year: 2013
Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
Author(s): Ding Q | Zhan J
Volume: 2013
Issue: default
Year: 2013
Author(s): Ding Q | Zhan J Volume: 2013 Issue: default Year: 2013
Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
Author(s): Tian WW | Wang QQ | Liu WD | Shen JP | Wang HS
Volume: 2013
Issue: default
Year: 2013
Author(s): Tian WW | Wang QQ | Liu WD | Shen JP | Wang HS Volume: 2013 Issue: default Year: 2013
Glyphosate and AMPA inhibit cancer cell growth through inhibiting intracellular glycine synthesis
Author(s): Li Q | Lambrechts MJ | Zhang Q | Liu S | Ge D | Yin R | Xi M | You Z
Volume: 2013
Issue: default
Year: 2013
Author(s): Li Q | Lambrechts MJ | Zhang Q | Liu S | Ge D | Yin R | Xi M | You Z Volume: 2013 Issue: default Year: 2013
Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial
Author(s): Maneeton B | Maneeton N | Srisurapanont M | Chittawatanarat K
Volume: 2013
Issue: default
Year: 2013
Author(s): Maneeton B | Maneeton N | Srisurapanont M | Chittawatanarat K Volume: 2013 Issue: default Year: 2013
Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis
Author(s): Hohenforst-Schmidt W | Petermann A | Visouli A | Zarogoulidis P | Darwiche K | Kougioumtzi I | Tsakiridis K | Machairiotis N | Ketteler M | Zarogoulidis K | Brachmann J
Volume: 2013
Issue: default
Year: 2013
Author(s): Hohenforst-Schmidt W | Petermann A | Visouli A | Zarogoulidis P | Darwiche K | Kougioumtzi I | Tsakiridis K | Machairiotis N | Ketteler M | Zarogoulidis K | Brachmann J Volume: 2013 Issue: default Year: 2013
Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine
Author(s): Noveck RJ | Douglas PS | Chow SC | Mangum B | Kori S | Kellerman DJ
Volume: 2013
Issue: default
Year: 2013
Author(s): Noveck RJ | Douglas PS | Chow SC | Mangum B | Kori S | Kellerman DJ Volume: 2013 Issue: default Year: 2013
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
Author(s): Zarogoulidis K | Ziogas E | Boutsikou E | Zarogoulidis P | Darwiche K | Kontakiotis T | Tsakiridis K | Porpodis K | Latsios D | Chatzizisi O | Karapantzos I | Li Q | Kyriazis G
Volume: 2013
Issue: default
Year: 2013
Author(s): Zarogoulidis K | Ziogas E | Boutsikou E | Zarogoulidis P | Darwiche K | Kontakiotis T | Tsakiridis K | Porpodis K | Latsios D | Chatzizisi O | Karapantzos I | Li Q | Kyriazis G Volume: 2013 Issue: default Year: 2013
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
Author(s): Rossini M | Lello S | Sblendorio I | Viapiana O | Fracassi E | Adami S | Gatti D
Volume: 2013
Issue: default
Year: 2013
Author(s): Rossini M | Lello S | Sblendorio I | Viapiana O | Fracassi E | Adami S | Gatti D Volume: 2013 Issue: default Year: 2013
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
Author(s): Hohenforst-Schmidt W | Zarogoulidis P | Darwiche K | Vogl T | Goldberg EP | Huang H | Simoff M | Li Q | Browning R | Turner FJ | Le Pivert P | Spyratos D | Zarogoulidis K | Celikoglu SI | Celikoglu F | Brachmann J
Volume: 2013
Issue: default
Year: 2013
Author(s): Hohenforst-Schmidt W | Zarogoulidis P | Darwiche K | Vogl T | Goldberg EP | Huang H | Simoff M | Li Q | Browning R | Turner FJ | Le Pivert P | Spyratos D | Zarogoulidis K | Celikoglu SI | Celikoglu F | Brachmann J Volume: 2013 Issue: default Year: 2013
Organelle targeting: third level of drug targeting
Author(s): Sakhrani NM | Padh H
Volume: 2013
Issue: default
Year: 2013
Author(s): Sakhrani NM | Padh H Volume: 2013 Issue: default Year: 2013
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
Author(s): Panos GD | Gatzioufas Z | Petropoulos IK | Dardabounis D | Thumann G | Hafezi F
Volume: 2013
Issue: default
Year: 2013
Author(s): Panos GD | Gatzioufas Z | Petropoulos IK | Dardabounis D | Thumann G | Hafezi F Volume: 2013 Issue: default Year: 2013
Endogenous n 3 polyunsaturated fatty acids PUFAs mitigate ovariectomy-induced bone loss by attenuating bone marrow adipogenesis in FAT1 transgenic mice
Author(s): Chen TY | Zhang ZM | Zheng XC | Wang L | Huang MJ | Qin S | Chen J | Lai PL | Yang CL | Liu J | Dai YF | Jin DD | Bai XC
Volume: 2013
Issue: default
Year: 2013
Author(s): Chen TY | Zhang ZM | Zheng XC | Wang L | Huang MJ | Qin S | Chen J | Lai PL | Yang CL | Liu J | Dai YF | Jin DD | Bai XC Volume: 2013 Issue: default Year: 2013
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
Author(s): Mazo DF | de Oliveira MG | Pereira IV | Cogliati B | Stefano JT | de Souza GF | Rabelo F | Lima FR | Ferreira Alves VA | Carrilho FJ | de Oliveira CP
Volume: 2013
Issue: default
Year: 2013
Author(s): Mazo DF | de Oliveira MG | Pereira IV | Cogliati B | Stefano JT | de Souza GF | Rabelo F | Lima FR | Ferreira Alves VA | Carrilho FJ | de Oliveira CP Volume: 2013 Issue: default Year: 2013
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
Author(s): Cowey CL
Volume: 2013
Issue: default
Year: 2013
Author(s): Cowey CL Volume: 2013 Issue: default Year: 2013
The drug efficacy and adverse reactions in a mouse model of oral squamous cell carcinoma treated with oxaliplatin at different time points during a day
Author(s): Yang K | Zhao N | Zhao D | Chen D | Li Y
Volume: 2013
Issue: default
Year: 2013
Author(s): Yang K | Zhao N | Zhao D | Chen D | Li Y Volume: 2013 Issue: default Year: 2013
A comparative study of the effects of vitamin C, sirolimus, and paclitaxel on the growth of endothelial and smooth muscle cells for cardiovascular medical device applications
Author(s): Kakade S | Mani G
Volume: 2013
Issue: default
Year: 2013
Author(s): Kakade S | Mani G Volume: 2013 Issue: default Year: 2013
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
Author(s): Woodcock HV | Molyneaux PL | Maher TM
Volume: 2013
Issue: default
Year: 2013
Author(s): Woodcock HV | Molyneaux PL | Maher TM Volume: 2013 Issue: default Year: 2013
Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells
Author(s): Lee HC | Ling QD | Yu WC | Hung CM | Kao TC | Huang YW | Higuchi A
Volume: 2013
Issue: default
Year: 2013
Author(s): Lee HC | Ling QD | Yu WC | Hung CM | Kao TC | Huang YW | Higuchi A Volume: 2013 Issue: default Year: 2013
Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR
Author(s): Jayaraman P | Sakharkar KR | Lim CS | Siddiqi MI | Dhillon SK | Sakharkar MK
Volume: 2013
Issue: default
Year: 2013
Author(s): Jayaraman P | Sakharkar KR | Lim CS | Siddiqi MI | Dhillon SK | Sakharkar MK Volume: 2013 Issue: default Year: 2013
Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study
Author(s): Cheng SL | Wang HC | Kuo SH
Volume: 2013
Issue: default
Year: 2013
Author(s): Cheng SL | Wang HC | Kuo SH Volume: 2013 Issue: default Year: 2013
Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
Author(s): Tranos P | Vakalis A | Asteriadis S | Koukoula S | Vachtsevanos A | Perganta G | Georgalas I
Volume: 2013
Issue: default
Year: 2013
Author(s): Tranos P | Vakalis A | Asteriadis S | Koukoula S | Vachtsevanos A | Perganta G | Georgalas I Volume: 2013 Issue: default Year: 2013
Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study
Author(s): Sakr FM | Gado AMI | Mohammed HR | Adam ANI
Volume: 2013
Issue: default
Year: 2013
Author(s): Sakr FM | Gado AMI | Mohammed HR | Adam ANI Volume: 2013 Issue: default Year: 2013
Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization
Author(s): Zych C | Domling A | Ayyavoo V
Volume: 2013
Issue: default
Year: 2013
Author(s): Zych C | Domling A | Ayyavoo V Volume: 2013 Issue: default Year: 2013
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
Author(s): Messenger WB | Beardsley RM | Flaxel CJ
Volume: 2013
Issue: default
Year: 2013
Author(s): Messenger WB | Beardsley RM | Flaxel CJ Volume: 2013 Issue: default Year: 2013
Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults
Author(s): Mula M
Volume: 2013
Issue: default
Year: 2013
Author(s): Mula M Volume: 2013 Issue: default Year: 2013
Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets ß-catenin
Author(s): Nath N | Liu X | Jacobs L | Kashfi K
Volume: 2013
Issue: default
Year: 2013
Author(s): Nath N | Liu X | Jacobs L | Kashfi K Volume: 2013 Issue: default Year: 2013
Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study
Author(s): Kono Y | Fukuda S | Shimada K | Nakanishi K | Otsuka K | Kubo T | Jissho S | Taguchi H | Yoshikawa J | Yoshiyama M
Volume: 2013
Issue: default
Year: 2013
Author(s): Kono Y | Fukuda S | Shimada K | Nakanishi K | Otsuka K | Kubo T | Jissho S | Taguchi H | Yoshikawa J | Yoshiyama M Volume: 2013 Issue: default Year: 2013
Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment
Author(s): Ibsen S | Schutt CE | Esener S
Volume: 2013
Issue: default
Year: 2013
Author(s): Ibsen S | Schutt CE | Esener S Volume: 2013 Issue: default Year: 2013
Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis – a multicenter, randomized, investigator-masked, parallel group study in Chinese patients
Author(s): Lin T | Gong L | Sun XH | Zhao NQ | Chen W | Yuan HP | Shao Y | Gao MH | Tang H
Volume: 2013
Issue: default
Year: 2013
Author(s): Lin T | Gong L | Sun XH | Zhao NQ | Chen W | Yuan HP | Shao Y | Gao MH | Tang H Volume: 2013 Issue: default Year: 2013
Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis
Author(s): Pitari GM
Volume: 2013
Issue: default
Year: 2013
Author(s): Pitari GM Volume: 2013 Issue: default Year: 2013
Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
Author(s): Takami T | Saito Y
Volume: 2013
Issue: default
Year: 2013
Author(s): Takami T | Saito Y Volume: 2013 Issue: default Year: 2013
Profile of certolizumab and its potential in the treatment of psoriatic arthritis
Author(s): Chimenti MS | Saraceno R | Chiricozzi A | Giunta A | Chimenti S | Perricone R
Volume: 2013
Issue: default
Year: 2013
Author(s): Chimenti MS | Saraceno R | Chiricozzi A | Giunta A | Chimenti S | Perricone R Volume: 2013 Issue: default Year: 2013
Current and emerging pharmacological treatments for sarcoidosis: a review
Author(s): Beegle SH | Barba K | Gobunsuy R | Judson MA
Volume: 2013
Issue: default
Year: 2013
Author(s): Beegle SH | Barba K | Gobunsuy R | Judson MA Volume: 2013 Issue: default Year: 2013
In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation
Author(s): Lim SCB | Paech MJ | Sunderl | B | Liu Y
Volume: 2013
Issue: default
Year: 2013
Author(s): Lim SCB | Paech MJ | Sunderl | B | Liu Y Volume: 2013 Issue: default Year: 2013
Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis
Author(s): Miyoshi S | Hamada H | Ito R | Katayama H | Irifune K | Suwaki T | Nakanishi N | Kanematsu T | Dote K | Aibiki M | Okura T | Higaki J
Volume: 2013
Issue: default
Year: 2013
Author(s): Miyoshi S | Hamada H | Ito R | Katayama H | Irifune K | Suwaki T | Nakanishi N | Kanematsu T | Dote K | Aibiki M | Okura T | Higaki J Volume: 2013 Issue: default Year: 2013
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
Author(s): Armuzzi A | Pugliese D | Nardone OM | Guidi L
Volume: 2013
Issue: default
Year: 2013
Author(s): Armuzzi A | Pugliese D | Nardone OM | Guidi L Volume: 2013 Issue: default Year: 2013
Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
Author(s): Gueler I | Mueller S | Helmschrott M | Oeing CU | Erbel C | Frankenstein L | Gleissner C | Ruhparwar A | Ehlermann P | Dengler TJ | Katus HA | Doesch AO
Volume: 2013
Issue: default
Year: 2013
Author(s): Gueler I | Mueller S | Helmschrott M | Oeing CU | Erbel C | Frankenstein L | Gleissner C | Ruhparwar A | Ehlermann P | Dengler TJ | Katus HA | Doesch AO Volume: 2013 Issue: default Year: 2013
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics
Author(s): Liu L | Ma Y | Wang RL | Xu WR | Wang SQ | Chou KC
Volume: 2013
Issue: default
Year: 2013
Author(s): Liu L | Ma Y | Wang RL | Xu WR | Wang SQ | Chou KC Volume: 2013 Issue: default Year: 2013
Phentermine and topiramate for the management of obesity: a review
Author(s): Cosentino G | Conrad AO | Uwaifo GI
Volume: 2013
Issue: default
Year: 2013
Author(s): Cosentino G | Conrad AO | Uwaifo GI Volume: 2013 Issue: default Year: 2013
Effect of 7-Difluoromethyl-5, 4΄-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE-/- mice induced by a cholesterol-rich diet
Author(s): Zhang Y | Li L | You J | Cao J | Fu X
Volume: 2013
Issue: default
Year: 2013
Author(s): Zhang Y | Li L | You J | Cao J | Fu X Volume: 2013 Issue: default Year: 2013
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
Author(s): Urbina O | Ferrández O | Espona M | Salas E | Ferrández I | Grau S
Volume: 2013
Issue: default
Year: 2013
Author(s): Urbina O | Ferrández O | Espona M | Salas E | Ferrández I | Grau S Volume: 2013 Issue: default Year: 2013
New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
Author(s): Palfreeman AC | McNamee KE | McCann FE
Volume: 2013
Issue: default
Year: 2013
Author(s): Palfreeman AC | McNamee KE | McCann FE Volume: 2013 Issue: default Year: 2013
Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks
Author(s): Mendyk A | Tuszyński PK | Polak S | Jachowicz R
Volume: 2013
Issue: default
Year: 2013
Author(s): Mendyk A | Tuszyński PK | Polak S | Jachowicz R Volume: 2013 Issue: default Year: 2013
Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn’s disease: a case report and review of the hypothetical association between TNF-α blockers and cancer
Author(s): Kouklakis G | Efremidou EI | Pitiakoudis M | Liratzopoulos N | Polychronidis AC
Volume: 2013
Issue: default
Year: 2013
Author(s): Kouklakis G | Efremidou EI | Pitiakoudis M | Liratzopoulos N | Polychronidis AC Volume: 2013 Issue: default Year: 2013
Hepatocyte-targeting gene transfer mediated by galactosylated poly(ethylene glycol)- graft-polyethylenimine derivative
Author(s): Wang YQ | Su J | Cai WW | Lu P | Yuan LF | Jin T | Chen SY | Sheng J
Volume: 2013
Issue: default
Year: 2013
Author(s): Wang YQ | Su J | Cai WW | Lu P | Yuan LF | Jin T | Chen SY | Sheng J Volume: 2013 Issue: default Year: 2013
Novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogs as antibacterial agents: a structural activity relationship
Author(s): Hussin WA | Ismail MA | El-Sayed WM
Volume: 2013
Issue: default
Year: 2013
Author(s): Hussin WA | Ismail MA | El-Sayed WM Volume: 2013 Issue: default Year: 2013
Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
Author(s): Takami T | Saito Y
Volume: 2013
Issue: default
Year: 2013
Author(s): Takami T | Saito Y Volume: 2013 Issue: default Year: 2013
Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
Author(s): Dai ZJ | Gao J | Kang HF | Ma YG | Ma XB | Lu WF | Lin S | Ma HB | Wang XJ | Wu WY
Volume: 2013
Issue: default
Year: 2013
Author(s): Dai ZJ | Gao J | Kang HF | Ma YG | Ma XB | Lu WF | Lin S | Ma HB | Wang XJ | Wu WY Volume: 2013 Issue: default Year: 2013
Successful management of an inadvertent excessive treprostinil overdose
Author(s): Hohenforst-Schmidt W | Hornig J | Friedel N | Zarogoulidis P | Zarogoulidis K | Brachmann J
Volume: 2013
Issue: default
Year: 2013
Author(s): Hohenforst-Schmidt W | Hornig J | Friedel N | Zarogoulidis P | Zarogoulidis K | Brachmann J Volume: 2013 Issue: default Year: 2013
A review of tasquinimod in the treatment of advanced prostate cancer
Author(s): Williamson SC | Hartley AE | Heer R
Volume: 2013
Issue: default
Year: 2013
Author(s): Williamson SC | Hartley AE | Heer R Volume: 2013 Issue: default Year: 2013
Alemtuzumab: evidence for its potential in relapsing–remitting multiple sclerosis
Author(s): Brown JWL | Coles AJ
Volume: 2013
Issue: default
Year: 2013
Author(s): Brown JWL | Coles AJ Volume: 2013 Issue: default Year: 2013
The therapeutic efficacy of propranolol in children with recurrent primary epistaxis
Author(s): Bjelakovic B | Bojanovic M | Lukic S | Saranac L | Vukomanovic V | Prijic S | Zivkovic N | Randjelovic D
Volume: 2013
Issue: default
Year: 2013
Author(s): Bjelakovic B | Bojanovic M | Lukic S | Saranac L | Vukomanovic V | Prijic S | Zivkovic N | Randjelovic D Volume: 2013 Issue: default Year: 2013
Advances with RNA interference in Alzheimer’s disease research
Author(s): Chen S | Ge X | Chen Y | Lv N | Liu Z | Yuan W
Volume: 2013
Issue: default
Year: 2013
Author(s): Chen S | Ge X | Chen Y | Lv N | Liu Z | Yuan W Volume: 2013 Issue: default Year: 2013
Profile of alisporivir and its potential in the treatment of hepatitis C
Author(s): Gallay PA | Lin K
Volume: 2013
Issue: default
Year: 2013
Author(s): Gallay PA | Lin K Volume: 2013 Issue: default Year: 2013
Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes
Author(s): Giampietro O | Giampietro C | Della Bartola L | Masoni MC | Matteucci E
Volume: 2013
Issue: default
Year: 2013
Author(s): Giampietro O | Giampietro C | Della Bartola L | Masoni MC | Matteucci E Volume: 2013 Issue: default Year: 2013
An early indicator of drug success: Top Journal Selectivity Index
Author(s): Kissin I
Volume: 2013
Issue: default
Year: 2013
Author(s): Kissin I Volume: 2013 Issue: default Year: 2013
Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogs
Author(s): El-Sayed WM | Hussin WA
Volume: 2013
Issue: default
Year: 2013
Author(s): El-Sayed WM | Hussin WA Volume: 2013 Issue: default Year: 2013
Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation
Author(s): Wu X | Hayes D Jr | Zwischenberger JB | Kuhn RJ | Mansour HM
Volume: 2013
Issue: default
Year: 2013
Author(s): Wu X | Hayes D Jr | Zwischenberger JB | Kuhn RJ | Mansour HM Volume: 2013 Issue: default Year: 2013
Emerging treatment options for nasopharyngeal carcinoma
Author(s): Zhang L | Chen QY | Liu H | Tang LQ | Mai HQ
Volume: 2013
Issue: default
Year: 2013
Author(s): Zhang L | Chen QY | Liu H | Tang LQ | Mai HQ Volume: 2013 Issue: default Year: 2013
Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment
Author(s): Chang CY | Hong JY | Yuan MK | Chang SJ | Lee YM | Chang SC | Hsu LC | Cheng SL
Volume: 2013
Issue: default
Year: 2013
Author(s): Chang CY | Hong JY | Yuan MK | Chang SJ | Lee YM | Chang SC | Hsu LC | Cheng SL Volume: 2013 Issue: default Year: 2013
Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry® yellow 20A82938 on an industrial scale
Author(s): Zaid AN | Natour S | Qaddomi A | Abu Ghoush A
Volume: 2013
Issue: default
Year: 2013
Author(s): Zaid AN | Natour S | Qaddomi A | Abu Ghoush A Volume: 2013 Issue: default Year: 2013
Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement
Author(s): Malagola R | Arrico L | Giannotti R | Pattavina L
Volume: 2013
Issue: default
Year: 2013
Author(s): Malagola R | Arrico L | Giannotti R | Pattavina L Volume: 2013 Issue: default Year: 2013
Hippuric acid nanocomposite enhances doxorubicin and oxaliplatin-induced cytotoxicity in MDA-MB231, MCF-7 and Caco2 cell lines
Author(s): Hussein Al Ali SH | Al-Qubaisi M | Hussein MZ | Ismail M | Bullo S
Volume: 2013
Issue: default
Year: 2013
Author(s): Hussein Al Ali SH | Al-Qubaisi M | Hussein MZ | Ismail M | Bullo S Volume: 2013 Issue: default Year: 2013
New treatments for myasthenia: a focus on antisense oligonucleotides
Author(s): Angelini C | Martignago S | Bisciglia M
Volume: 2013
Issue: default
Year: 2013
Author(s): Angelini C | Martignago S | Bisciglia M Volume: 2013 Issue: default Year: 2013
Impact of ghrelin on vitreous cytokine levels in an experimental uveitis model
Author(s): Turgut B | Gul FC | Dagli F | Ilhan N | Ozgen M
Volume: 2013
Issue: default
Year: 2013
Author(s): Turgut B | Gul FC | Dagli F | Ilhan N | Ozgen M Volume: 2013 Issue: default Year: 2013
Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain
Author(s): Palmieri B | Rottigni V | Iannitti T
Volume: 2013
Issue: default
Year: 2013
Author(s): Palmieri B | Rottigni V | Iannitti T Volume: 2013 Issue: default Year: 2013
Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study
Author(s): Ersoy H | Yaytokgil M | Karakoyunlu AN | Topaloglu H | Sagnak L | Ozok HU
Volume: 2013
Issue: default
Year: 2012
Author(s): Ersoy H | Yaytokgil M | Karakoyunlu AN | Topaloglu H | Sagnak L | Ozok HU Volume: 2013 Issue: default Year: 2012
Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
Author(s): Smith WB | Mannaert E | Verhaeghe T | Kerstens R | Vandeplassche L | Van de Velde V
Volume: 2012
Issue: default
Year: 2012
Author(s): Smith WB | Mannaert E | Verhaeghe T | Kerstens R | Vandeplassche L | Van de Velde V Volume: 2012 Issue: default Year: 2012
Dabrafenib and its potential for the treatment of metastatic melanoma
Author(s): Menzies AM | Long GV | Murali R
Volume: 2012
Issue: default
Year: 2012
Author(s): Menzies AM | Long GV | Murali R Volume: 2012 Issue: default Year: 2012
Update on taxane development: new analogs and new formulations
Author(s): Yared JA | Tkaczuk KH
Volume: 2012
Issue: default
Year: 2012
Author(s): Yared JA | Tkaczuk KH Volume: 2012 Issue: default Year: 2012
Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?
Author(s): Hohenforst-Schmidt W | Riedel A | Zarogoulidis P | Franke C | Gschwendtner A | Huang H | Machairiotis N | Dramba V | Zarogoulidis K | Brachmann J
Volume: 2012
Issue: default
Year: 2012
Author(s): Hohenforst-Schmidt W | Riedel A | Zarogoulidis P | Franke C | Gschwendtner A | Huang H | Machairiotis N | Dramba V | Zarogoulidis K | Brachmann J Volume: 2012 Issue: default Year: 2012
Pretreatment data is highly predictive of liver chemistry signals in clinical trials
Author(s): Cai Z | Bresell A | Steinberg MH | Silberg DG | Furlong ST
Volume: 2012
Issue: default
Year: 2012
Author(s): Cai Z | Bresell A | Steinberg MH | Silberg DG | Furlong ST Volume: 2012 Issue: default Year: 2012
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
Author(s): Yang X | Chen Y | Hong X | Wu N | Song L,Yuan W | Liu Z
Volume: 2012
Issue: default
Year: 2012
Author(s): Yang X | Chen Y | Hong X | Wu N | Song L,Yuan W | Liu Z Volume: 2012 Issue: default Year: 2012
Potential role of rivaroxaban in patients with acute coronary syndrome
Author(s): Fitchett DH
Volume: 2012
Issue: default
Year: 2012
Author(s): Fitchett DH Volume: 2012 Issue: default Year: 2012
Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
Author(s): Wempe MF | Lightner JW | Miller B | Iwen TJ | Rice PJ | Wakui S | Anzai N | Jutabha P | Endou H
Volume: 2012
Issue: default
Year: 2012
Author(s): Wempe MF | Lightner JW | Miller B | Iwen TJ | Rice PJ | Wakui S | Anzai N | Jutabha P | Endou H Volume: 2012 Issue: default Year: 2012
Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors
Author(s): Xiao HT | Liao Z | Tong RS
Volume: 2012
Issue: default
Year: 2012
Author(s): Xiao HT | Liao Z | Tong RS Volume: 2012 Issue: default Year: 2012
Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects
Author(s): Tjandrawinata RR | Setiawati E | Yunaidi DA | Santoso ID | Setiawati A | Susanto LW
Volume: 2012
Issue: default
Year: 2012
Author(s): Tjandrawinata RR | Setiawati E | Yunaidi DA | Santoso ID | Setiawati A | Susanto LW Volume: 2012 Issue: default Year: 2012
Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
Author(s): Ruiz de Garibay AP | Delgado D | del Pozo-Rodríguez A | Solinís MA | Gascón AR
Volume: 2012
Issue: default
Year: 2012
Author(s): Ruiz de Garibay AP | Delgado D | del Pozo-Rodríguez A | Solinís MA | Gascón AR Volume: 2012 Issue: default Year: 2012
Therapy effects of gold nanorods on the CNE-1 nasopharyngeal carcinoma cell line
Author(s): Shao J | Tang J | Ji J | Zhou W
Volume: 2012
Issue: default
Year: 2012
Author(s): Shao J | Tang J | Ji J | Zhou W Volume: 2012 Issue: default Year: 2012
Efficacy of two novel 2,2’-bifurans to inhibit methicillin-resistant Staphylococcus aureus infection in male mice in comparison to vancomycin
Author(s): El-Sayed WM | Hussin WA | Ismail MA
Volume: 2012
Issue: default
Year: 2012
Author(s): El-Sayed WM | Hussin WA | Ismail MA Volume: 2012 Issue: default Year: 2012
Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
Author(s): Doesch AO | Repp J | Hofmann N | Erbel C | Frankenstein L | Gleissner CA | Schmidt C | Ruhparwar A | Zugck C | Schnitzler P | Ehlermann P | Dengler TJ | Katus HA
Volume: 2012
Issue: default
Year: 2012
Author(s): Doesch AO | Repp J | Hofmann N | Erbel C | Frankenstein L | Gleissner CA | Schmidt C | Ruhparwar A | Zugck C | Schnitzler P | Ehlermann P | Dengler TJ | Katus HA Volume: 2012 Issue: default Year: 2012
Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis
Author(s): Tsuboko Y | Takeda S | Mii S | Nakazato K | Tanaka K | Uchida E | Sakamoto A
Volume: 2012
Issue: default
Year: 2012
Author(s): Tsuboko Y | Takeda S | Mii S | Nakazato K | Tanaka K | Uchida E | Sakamoto A Volume: 2012 Issue: default Year: 2012
Current and novel drug therapies for idiopathic pulmonary fibrosis
Author(s): Adamali HI | Maher TM
Volume: 2012
Issue: default
Year: 2012
Author(s): Adamali HI | Maher TM Volume: 2012 Issue: default Year: 2012
Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
Author(s): Goldberg AS | Hegele RA
Volume: 2012
Issue: default
Year: 2012
Author(s): Goldberg AS | Hegele RA Volume: 2012 Issue: default Year: 2012
Kinase inhibitors: a new class of antirheumatic drugs
Author(s): Kyttaris VC
Volume: 2012
Issue: default
Year: 2012
Author(s): Kyttaris VC Volume: 2012 Issue: default Year: 2012
Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
Author(s): Lambert O | Bandilla D
Volume: 2012
Issue: default
Year: 2012
Author(s): Lambert O | Bandilla D Volume: 2012 Issue: default Year: 2012
Adding thiazide to a rennin-angiotensin blocker regimen to improve left ventricular relaxation in diabetes and nondiabetes patients with hypertension
Author(s): Takami T | Ito H | Ishii K | Shimada K | Iwakura K | Watanabe H | Fukuda S | Yoshikawa J
Volume: 2012
Issue: default
Year: 2012
Author(s): Takami T | Ito H | Ishii K | Shimada K | Iwakura K | Watanabe H | Fukuda S | Yoshikawa J Volume: 2012 Issue: default Year: 2012
Exploring prospects of novel drugs for tuberculosis
Author(s): Janssen S | Jayachandran R | Khathi L | Zinsstag J | Grobusch MP | Pieters J
Volume: 2012
Issue: default
Year: 2012
Author(s): Janssen S | Jayachandran R | Khathi L | Zinsstag J | Grobusch MP | Pieters J Volume: 2012 Issue: default Year: 2012
Natural material adsorbed onto a polymer to enhance immune function
Author(s): Reinaque AP | França EL | Scherer EF | Côrtes MA | Souto FJ | Honorio-França AC
Volume: 2012
Issue: default
Year: 2012
Author(s): Reinaque AP | França EL | Scherer EF | Côrtes MA | Souto FJ | Honorio-França AC Volume: 2012 Issue: default Year: 2012
Emerging options for the management of scorpion stings
Author(s): Chippaux JP
Volume: 2012
Issue: default
Year: 2012
Author(s): Chippaux JP Volume: 2012 Issue: default Year: 2012
Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies
Author(s): Kalnins D | Wilschanski M
Volume: 2012
Issue: default
Year: 2012
Author(s): Kalnins D | Wilschanski M Volume: 2012 Issue: default Year: 2012
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
Author(s): Frati F | Incorvaia C | David M | Scurati S | Seta S | Padua G | Cattaneo E | Cavaliere C | Di Rienzo A | Dell'Albani I | Puccinelli P
Volume: 2012
Issue: default
Year: 2012
Author(s): Frati F | Incorvaia C | David M | Scurati S | Seta S | Padua G | Cattaneo E | Cavaliere C | Di Rienzo A | Dell'Albani I | Puccinelli P Volume: 2012 Issue: default Year: 2012
Update on the development of lurasidone as a treatment for patients with acute schizophrenia
Author(s): Yasui-Furukori N
Volume: 2012
Issue: default
Year: 2012
Author(s): Yasui-Furukori N Volume: 2012 Issue: default Year: 2012
Imiglucerase in the treatment of Gaucher disease: a history and perspective
Author(s): Deegan PB | Cox TM
Volume: 2012
Issue: default
Year: 2012
Author(s): Deegan PB | Cox TM Volume: 2012 Issue: default Year: 2012
A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers
Author(s): Golor G | Hu K | Ruffin M | Buchelt A | Bouillaud E | Wang Y | Maldonado M
Volume: 2012
Issue: default
Year: 2012
Author(s): Golor G | Hu K | Ruffin M | Buchelt A | Bouillaud E | Wang Y | Maldonado M Volume: 2012 Issue: default Year: 2012
Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted
Author(s): Lambert O | Bandilla D | Iyer R | Witchey-Lakshmanan L | Palepu N
Volume: 2012
Issue: default
Year: 2012
Author(s): Lambert O | Bandilla D | Iyer R | Witchey-Lakshmanan L | Palepu N Volume: 2012 Issue: default Year: 2012
Why (not) go east? Comparison of findings from FDA Investigational New Drug study site inspections performed in Central and Eastern Europe with results from the USA, Western Europe, and other parts of the world
Author(s): Caldron PH | Gavrilova SI | Kropf S
Volume: 2012
Issue: default
Year: 2012
Author(s): Caldron PH | Gavrilova SI | Kropf S Volume: 2012 Issue: default Year: 2012
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
Author(s): Kones R
Volume: 2011
Issue: default
Year: 2011
Author(s): Kones R Volume: 2011 Issue: default Year: 2011
Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial
Author(s): Simsarian JP | Saunders C | Smith DM
Volume: 2011
Issue: default
Year: 2011
Author(s): Simsarian JP | Saunders C | Smith DM Volume: 2011 Issue: default Year: 2011
Osteoporosis – a current view of pharmacological prevention and treatment
Author(s): Das S | Crockett JC
Volume: 2013
Issue: default
Year: 2013
Author(s): Das S | Crockett JC Volume: 2013 Issue: default Year: 2013
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
Author(s): Dickens JA | Lomas DA
Volume: 2011
Issue: default
Year: 2011
Author(s): Dickens JA | Lomas DA Volume: 2011 Issue: default Year: 2011
Emerging options in growth hormone therapy: an update
Author(s): Kemp SF | Frindik JP
Volume: 2011
Issue: default
Year: 2011
Author(s): Kemp SF | Frindik JP Volume: 2011 Issue: default Year: 2011
Investigation of the antibacterial activity of pioglitazone
Author(s): Masadeh MM | Mhaidat NM | Al-Azzam SI | Alzoubi KH
Volume: 2011
Issue: default
Year: 2011
Author(s): Masadeh MM | Mhaidat NM | Al-Azzam SI | Alzoubi KH Volume: 2011 Issue: default Year: 2011
Future prospects in the treatment of erectile dysfunction: focus on avanafil
Author(s): Alwaal A | Al-Mannie R | Carrier S
Volume: 2011
Issue: default
Year: 2011
Author(s): Alwaal A | Al-Mannie R | Carrier S Volume: 2011 Issue: default Year: 2011
Bioequivalence assessment of two formulations of ibuprofen
Author(s): Al-Talla ZA | Akrawi SH | Tolley LT | Sioud SH | Zaater MF | Emwas AHM
Volume: 2011
Issue: default
Year: 2011
Author(s): Al-Talla ZA | Akrawi SH | Tolley LT | Sioud SH | Zaater MF | Emwas AHM Volume: 2011 Issue: default Year: 2011
Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates
Author(s): Muratore M | Quarta E | Grimaldi A | Calcagnile F | Quarta L
Volume: 2011
Issue: default
Year: 2011
Author(s): Muratore M | Quarta E | Grimaldi A | Calcagnile F | Quarta L Volume: 2011 Issue: default Year: 2011
Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release
Author(s): Benedek IH | Jobes J | Xiang Q | Fiske WD
Volume: 2011
Issue: default
Year: 2011
Author(s): Benedek IH | Jobes J | Xiang Q | Fiske WD Volume: 2011 Issue: default Year: 2011
The influence of operational parameters and feed preparation in a convective batch ribbon powder mixer
Author(s): Yeow ST | Shahar A | Abdul Aziz N | Anuar MS | Yusof YA | Taip FS
Volume: 2011
Issue: default
Year: 2011
Author(s): Yeow ST | Shahar A | Abdul Aziz N | Anuar MS | Yusof YA | Taip FS Volume: 2011 Issue: default Year: 2011
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond
Author(s): Ou SH
Volume: 2011
Issue: default
Year: 2011
Author(s): Ou SH Volume: 2011 Issue: default Year: 2011
Corrigendum
Author(s): Escobar-Chávez JJ | Domínguez-Delgado CL | Rodríguez-Cruz IM
Volume: 2011
Issue: default
Year: 2011
Author(s): Escobar-Chávez JJ | Domínguez-Delgado CL | Rodríguez-Cruz IM Volume: 2011 Issue: default Year: 2011
Profile of ipilimumab and its role in the treatment of metastatic melanoma
Author(s): Patel SP | Woodman SE
Volume: 2011
Issue: default
Year: 2011
Author(s): Patel SP | Woodman SE Volume: 2011 Issue: default Year: 2011
Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease
Author(s): Nordfjeld K | Andreasen H | Thomsen LL
Volume: 2012
Issue: default
Year: 2012
Author(s): Nordfjeld K | Andreasen H | Thomsen LL Volume: 2012 Issue: default Year: 2012
Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations
Author(s): Sahib MN | Abdulameer SA | Darwis Y | Peh KK | Tan YT
Volume: 2012
Issue: default
Year: 2012
Author(s): Sahib MN | Abdulameer SA | Darwis Y | Peh KK | Tan YT Volume: 2012 Issue: default Year: 2012
Treatment for primary hypothyroidism: current approaches and future possibilities
Author(s): Chakera AJ | Pearce SHS | Vaidya B
Volume: 2012
Issue: default
Year: 2011
Author(s): Chakera AJ | Pearce SHS | Vaidya B Volume: 2012 Issue: default Year: 2011
Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
Author(s): Rehman Y | Rosenberg JE
Volume: 2012
Issue: default
Year: 2012
Author(s): Rehman Y | Rosenberg JE Volume: 2012 Issue: default Year: 2012
Inhaled treprostinil: a therapeutic review
Author(s): Channick RN | Voswinckel R | Rubin LJ
Volume: 2012
Issue: default
Year: 2012
Author(s): Channick RN | Voswinckel R | Rubin LJ Volume: 2012 Issue: default Year: 2012
Effect of surfactant and surfactant blends on pseudoternary phase diagram behavior of newly synthesized palm kernel oil esters
Author(s): Mahdi ES | Sakeena MH | Abdulkarim MF | Abdullah GZ | Sattar MA | Noor AM
Volume: 2011
Issue: default
Year: 2011
Author(s): Mahdi ES | Sakeena MH | Abdulkarim MF | Abdullah GZ | Sattar MA | Noor AM Volume: 2011 Issue: default Year: 2011
Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells
Author(s): Tahanian E | Sanchez LA | Shiao TC | Roy R | Annabi B
Volume: 2011
Issue: default
Year: 2011
Author(s): Tahanian E | Sanchez LA | Shiao TC | Roy R | Annabi B Volume: 2011 Issue: default Year: 2011
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
Author(s): Kawai Y | Sato-Ishida R | Motoyama A | Kajinami K
Volume: 2011
Issue: default
Year: 2011
Author(s): Kawai Y | Sato-Ishida R | Motoyama A | Kajinami K Volume: 2011 Issue: default Year: 2011
Emerging strategies and therapies for treatment of Paget’s disease of bone
Author(s): Michou L | Brown JP
Volume: 2011
Issue: default
Year: 2011
Author(s): Michou L | Brown JP Volume: 2011 Issue: default Year: 2011
Targeting nicotine addiction: the possibility of a therapeutic vaccine
Author(s): Escobar-Chávez JJ | Domínguez-Delgado CL | Rodríguez-Cruz IM
Volume: 2011
Issue: default
Year: 2011
Author(s): Escobar-Chávez JJ | Domínguez-Delgado CL | Rodríguez-Cruz IM Volume: 2011 Issue: default Year: 2011
Current and emerging drugs for the treatment of inflammatory bowel disease
Author(s): Triantafillidis JK | Merikas E | Georgopoulos F
Volume: 2011
Issue: default
Year: 2011
Author(s): Triantafillidis JK | Merikas E | Georgopoulos F Volume: 2011 Issue: default Year: 2011
Drug discovery and development for neglected diseases: the DNDi model
Author(s): Eric Chatelain | Jean-Robert Ioset
Volume: 2011
Issue: default
Year: 2011
Author(s): Eric Chatelain | Jean-Robert Ioset Volume: 2011 Issue: default Year: 2011
Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel
Author(s): Andrew S Bomback | James A Tumlin | Joel Baranski | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Andrew S Bomback | James A Tumlin | Joel Baranski | et al Volume: 2011 Issue: default Year: 2011
Paliperidone extended-release: does it have a place in antipsychotic therapy?
Author(s): Maximilian Gahr | Markus A Kölle | Carlos Schönfeldt-Lecuona | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Maximilian Gahr | Markus A Kölle | Carlos Schönfeldt-Lecuona | et al Volume: 2011 Issue: default Year: 2011
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
Author(s): Channing J Paller | Emmanuel S Antonarakis
Volume: 2011
Issue: default
Year: 2011
Author(s): Channing J Paller | Emmanuel S Antonarakis Volume: 2011 Issue: default Year: 2011
The use of serotonergic drugs to treat obesity – is there any hope?
Author(s): Nicholas T Bello | Nu-Chu Liang
Volume: 2011
Issue: default
Year: 2011
Author(s): Nicholas T Bello | Nu-Chu Liang Volume: 2011 Issue: default Year: 2011
Cefditoren in upper and lower community-acquired respiratory tract infections
Author(s): Francisco Soriano | María-José Giménez | Lorenzo Aguilar
Volume: 2011
Issue: default
Year: 2011
Author(s): Francisco Soriano | María-José Giménez | Lorenzo Aguilar Volume: 2011 Issue: default Year: 2011
Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis
Author(s): Santa J Ono | Keith Lane
Volume: 2011
Issue: default
Year: 2011
Author(s): Santa J Ono | Keith Lane Volume: 2011 Issue: default Year: 2011
Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy
Author(s): Ofra Goldzweig | Philip J Hashkes
Volume: 2011
Issue: default
Year: 2011
Author(s): Ofra Goldzweig | Philip J Hashkes Volume: 2011 Issue: default Year: 2011
When is high-dose intravenous iron repletion needed? Assessing new treatment options
Author(s): David Gozzard
Volume: 2011
Issue: default
Year: 2011
Author(s): David Gozzard Volume: 2011 Issue: default Year: 2011
Review of the pharmacology and clinical studies of micafungin
Author(s): Alison M Bormann | Vicki A Morrison
Volume: 2009
Issue: default
Year: 2009
Author(s): Alison M Bormann | Vicki A Morrison Volume: 2009 Issue: default Year: 2009
Effect of combinations of antiviral drugs on herpes simplex encephalitis
Author(s): Bryan M Gebhardt | Federico Focher | Richard Eberle | et al
Volume: 2009
Issue: default
Year: 2009
Author(s): Bryan M Gebhardt | Federico Focher | Richard Eberle | et al Volume: 2009 Issue: default Year: 2009
Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
Author(s): Brian Casserly | James R Klinger
Volume: 2009
Issue: default
Year: 2009
Author(s): Brian Casserly | James R Klinger Volume: 2009 Issue: default Year: 2009
Conivaptan and its role in the treatment of hyponatremia
Author(s): Jalal K Ghali | Jareer O Farah | Suleiman Daifallah | et al
Volume: 2009
Issue: default
Year: 2009
Author(s): Jalal K Ghali | Jareer O Farah | Suleiman Daifallah | et al Volume: 2009 Issue: default Year: 2009
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
Author(s): Ann Janssens | Marc Boogaerts | Gregor Verhoef
Volume: 2009
Issue: default
Year: 2009
Author(s): Ann Janssens | Marc Boogaerts | Gregor Verhoef Volume: 2009 Issue: default Year: 2009
A review of exenatide as adjunctive therapy in patients with type 2 diabetes
Author(s): Gisela I Robles | Devada Singh-Franco
Volume: 2009
Issue: default
Year: 2009
Author(s): Gisela I Robles | Devada Singh-Franco Volume: 2009 Issue: default Year: 2009
T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection
Author(s): Thomas H Waid | John S Thompson | Maria Siemionow | Stephen A Brown
Volume: 2009
Issue: default
Year: 2009
Author(s): Thomas H Waid | John S Thompson | Maria Siemionow | Stephen A Brown Volume: 2009 Issue: default Year: 2009
Management of advanced breast cancer with the epothilone B analog, ixabepilone
Author(s): William Gradishar
Volume: 2009
Issue: default
Year: 2009
Author(s): William Gradishar Volume: 2009 Issue: default Year: 2009
Characteristics of doripenem: a new broad-spectrum antibiotic
Author(s): Francisco Alvarez-Lerma | Santiago Grau | Olivia Ferrández
Volume: 2009
Issue: default
Year: 2009
Author(s): Francisco Alvarez-Lerma | Santiago Grau | Olivia Ferrández Volume: 2009 Issue: default Year: 2009
Oxybutynin extended release for the management of overactive bladder: a clinical review
Author(s): AM Arisco | EK Brantly | SR Kraus
Volume: 2009
Issue: default
Year: 2009
Author(s): AM Arisco | EK Brantly | SR Kraus Volume: 2009 Issue: default Year: 2009
Efficacy of epicutaneous Diractin® (ketoprofen in Transfersome® gel) for the treatment of pain related to eccentric muscle contractions
Author(s): Matthias Rother | Egbert J Seidel | Priscilla M Clarkson | Stefan Mazgareanu | et al.
Volume: 2009
Issue: default
Year: 2009
Author(s): Matthias Rother | Egbert J Seidel | Priscilla M Clarkson | Stefan Mazgareanu | et al. Volume: 2009 Issue: default Year: 2009
Indiplon in the management of insomnia
Author(s): Michael D Lemon | Joe D Strain | Annie M Hegg | Debra K Farver
Volume: 2009
Issue: default
Year: 2009
Author(s): Michael D Lemon | Joe D Strain | Annie M Hegg | Debra K Farver Volume: 2009 Issue: default Year: 2009
Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex
Author(s): Sorin J Brull | Mohamed Naguib
Volume: 2009
Issue: default
Year: 2009
Author(s): Sorin J Brull | Mohamed Naguib Volume: 2009 Issue: default Year: 2009
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
Author(s): Kari E Roberts | Ioana R Preston
Volume: 2009
Issue: default
Year: 2009
Author(s): Kari E Roberts | Ioana R Preston Volume: 2009 Issue: default Year: 2009
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
Author(s): Ronan Swords | Devalingam Mahalingam | Swaminathan Padmanabhan | Jennifer Carew | Francis Giles
Volume: 2009
Issue: default
Year: 2009
Author(s): Ronan Swords | Devalingam Mahalingam | Swaminathan Padmanabhan | Jennifer Carew | Francis Giles Volume: 2009 Issue: default Year: 2009
Oxidative stress-induced cell cycle blockage and a protease-independent programmed cell death in microaerophilic Giardia lamblia
Author(s): Esha Ghosh | Arjun Ghosh | Amar Nath Ghosh | Tomoyoshi Nozaki | Sandipan Ganguly
Volume: 2009
Issue: default
Year: 2009
Author(s): Esha Ghosh | Arjun Ghosh | Amar Nath Ghosh | Tomoyoshi Nozaki | Sandipan Ganguly Volume: 2009 Issue: default Year: 2009
Troglitazone reverses the multiple drug resistance phenotype in cancer cells
Author(s): Gerald F Davies | Bernhard HJ Juurlink | Troy AA Harkness
Volume: 2009
Issue: default
Year: 2009
Author(s): Gerald F Davies | Bernhard HJ Juurlink | Troy AA Harkness Volume: 2009 Issue: default Year: 2009
Newer treatments for decompensated heart failure: focus on levosimendan
Author(s): Ferenc Follath
Volume: 2009
Issue: default
Year: 2009
Author(s): Ferenc Follath Volume: 2009 Issue: default Year: 2009
Alitretinoin – its use in intractable hand eczema and other potential indications
Author(s): Bibi Petersen | Gregor BE Jemec
Volume: 2009
Issue: default
Year: 2009
Author(s): Bibi Petersen | Gregor BE Jemec Volume: 2009 Issue: default Year: 2009
Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry
Author(s): Klaus Braun | Manfred Wiessler | Volker Ehemann | Ruediger Pipkorn | Herbert Spring | et al
Volume: 2008
Issue: default
Year: 2009
Author(s): Klaus Braun | Manfred Wiessler | Volker Ehemann | Ruediger Pipkorn | Herbert Spring | et al Volume: 2008 Issue: default Year: 2009
The evolving role of alemtuzumab (Campath-1H) in renal transplantation
Author(s): Phuong-Thu T Pham | Gerald S Lipshutz | Phuong-Truc T Pham | Joseph Kawahji | Jennifer S Singer | Phuong-Chi T Pham
Volume: 2009
Issue: default
Year: 2008
Author(s): Phuong-Thu T Pham | Gerald S Lipshutz | Phuong-Truc T Pham | Joseph Kawahji | Jennifer S Singer | Phuong-Chi T Pham Volume: 2009 Issue: default Year: 2008
Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
Author(s): Katherine A Lewis | Erica A Eugster
Volume: 2009
Issue: default
Year: 2008
Author(s): Katherine A Lewis | Erica A Eugster Volume: 2009 Issue: default Year: 2008
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
Author(s): Thomas J Polascik
Volume: 2009
Issue: default
Year: 2008
Author(s): Thomas J Polascik Volume: 2009 Issue: default Year: 2008
Apoptotic and chemotherapeutic properties of iron(III)-salophene in an ovarian cancer animal model
Author(s): Thilo S Lange | Carolyn McCourt | Rakesh K Singh | Kyu Kwang Kim | Ajay P Singh | et al
Volume: 2009
Issue: default
Year: 2008
Author(s): Thilo S Lange | Carolyn McCourt | Rakesh K Singh | Kyu Kwang Kim | Ajay P Singh | et al Volume: 2009 Issue: default Year: 2008
Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
Author(s): Akito Natsume | Rinpei Niwa | Mitsuo Satoh
Volume: 2009
Issue: default
Year: 2008
Author(s): Akito Natsume | Rinpei Niwa | Mitsuo Satoh Volume: 2009 Issue: default Year: 2008
Ambrisentan for the treatment of pulmonary arterial hypertension
Author(s): Brian Casserly | James R Klinger
Volume: 2008
Issue: default
Year: 2008
Author(s): Brian Casserly | James R Klinger Volume: 2008 Issue: default Year: 2008
Drug design with Cdc7 kinase: a potential novel cancer therapy target
Author(s): Masaaki Sawa | Hisao Masai
Volume: 2008
Issue: default
Year: 2008
Author(s): Masaaki Sawa | Hisao Masai Volume: 2008 Issue: default Year: 2008
Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B
Author(s): Thomas Scior | Hans-Georg Mack | José Antonio Guevara García | Wolfhard Koch
Volume: 2008
Issue: default
Year: 2008
Author(s): Thomas Scior | Hans-Georg Mack | José Antonio Guevara García | Wolfhard Koch Volume: 2008 Issue: default Year: 2008
Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
Author(s): Andreas Wentrup | Wolfgang H Oertel | Richard Dodel
Volume: 2008
Issue: default
Year: 2008
Author(s): Andreas Wentrup | Wolfgang H Oertel | Richard Dodel Volume: 2008 Issue: default Year: 2008
Development and targeted use of nilotinib in chronic myeloid leukemia
Author(s): Carmen Fava | Hagop Kantarjian | Jorge Cortes | Elias Jabbour
Volume: 2008
Issue: default
Year: 2008
Author(s): Carmen Fava | Hagop Kantarjian | Jorge Cortes | Elias Jabbour Volume: 2008 Issue: default Year: 2008
Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
Author(s): Gina Ryan | Tim A Briscoe, Lynette Jobe
Volume: 2008
Issue: default
Year: 2008
Author(s): Gina Ryan | Tim A Briscoe, Lynette Jobe Volume: 2008 Issue: default Year: 2008
Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologies
Author(s): Nathan W Kopper | Jennifer Gudeman
Volume: 2008
Issue: default
Year: 2008
Author(s): Nathan W Kopper | Jennifer Gudeman Volume: 2008 Issue: default Year: 2008
Polyethylenimine-mediated gene delivery to the lung and therapeutic applications
Author(s): Sante Di Gioia | Massimo Conese
Volume: 2008
Issue: default
Year: 2008
Author(s): Sante Di Gioia | Massimo Conese Volume: 2008 Issue: default Year: 2008
Development of QSAR model for immunomodulatory activity of natural coumarinolignoids
Author(s): Dharmendra K Yadav | Abha Meena | Ankit Srivastava | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Dharmendra K Yadav | Abha Meena | Ankit Srivastava | et al Volume: 2010 Issue: default Year: 2010
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Author(s): Mark A Giembycz | Stephen K Field
Volume: 2010
Issue: default
Year: 2010
Author(s): Mark A Giembycz | Stephen K Field Volume: 2010 Issue: default Year: 2010
Emerging treatments in the management of schizophrenia – focus on sertindole
Author(s): Maria Rosaria A Muscatello | Antonio Bruno | Gianluca Pandolfo | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Maria Rosaria A Muscatello | Antonio Bruno | Gianluca Pandolfo | et al Volume: 2010 Issue: default Year: 2010
A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
Author(s): Samuel L Washington III | Alan W Shindel
Volume: 2010
Issue: default
Year: 2010
Author(s): Samuel L Washington III | Alan W Shindel Volume: 2010 Issue: default Year: 2010
Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
Author(s): Son V Pham | Phuong-Chi T Pham | Phuong-Mai T Pham | et al.
Volume: 2010
Issue: default
Year: 2010
Author(s): Son V Pham | Phuong-Chi T Pham | Phuong-Mai T Pham | et al. Volume: 2010 Issue: default Year: 2010
Thermosensitive Pluronic® hydrogel: prolonged injectable formulation for drug abuse
Author(s): Katayoun Derakhshandeh | Mahtab Fashi | Seyedalireza Seifoleslami
Volume: 2010
Issue: default
Year: 2010
Author(s): Katayoun Derakhshandeh | Mahtab Fashi | Seyedalireza Seifoleslami Volume: 2010 Issue: default Year: 2010
Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B
Author(s): Thomas Scior | José Antonio Guevara-García | FJ Melendez | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Thomas Scior | José Antonio Guevara-García | FJ Melendez | et al Volume: 2010 Issue: default Year: 2010
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
Author(s): Aarat M Patel | Larry W Moreland
Volume: 2010
Issue: default
Year: 2010
Author(s): Aarat M Patel | Larry W Moreland Volume: 2010 Issue: default Year: 2010
Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
Author(s): Ronald C Hamdy
Volume: 2010
Issue: default
Year: 2010
Author(s): Ronald C Hamdy Volume: 2010 Issue: default Year: 2010
Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine
Author(s): Linda Steinbaugh | Jerzy P Szaflarski
Volume: 2010
Issue: default
Year: 2010
Author(s): Linda Steinbaugh | Jerzy P Szaflarski Volume: 2010 Issue: default Year: 2010
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients
Author(s): Mark Kowalski | Joycelyn Entwistle | Jeannick Cizeau | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Mark Kowalski | Joycelyn Entwistle | Jeannick Cizeau | et al Volume: 2010 Issue: default Year: 2010
Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets
Author(s): Suhas S Khandave | Satish V Sawant | Santosh S Joshi | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Suhas S Khandave | Satish V Sawant | Santosh S Joshi | et al Volume: 2010 Issue: default Year: 2010
The use of lorcaserin in the management of obesity: a critical appraisal
Author(s): Bo Bai | Yu Wang
Volume: 2011
Issue: default
Year: 2010
Author(s): Bo Bai | Yu Wang Volume: 2011 Issue: default Year: 2010
Current progress in the development of a prophylactic vaccine for HIV-1
Author(s): Lena J Gamble | Qiana L Matthews
Volume: 2011
Issue: default
Year: 2010
Author(s): Lena J Gamble | Qiana L Matthews Volume: 2011 Issue: default Year: 2010
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
Author(s): Patrick A Schweizer | Rüdiger Becker | Hugo A Katus | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Patrick A Schweizer | Rüdiger Becker | Hugo A Katus | et al Volume: 2011 Issue: default Year: 2011
Current difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa
Author(s): Butros L | Boayue K | Mathew P
Volume: 2011
Issue: default
Year: 2011
Author(s): Butros L | Boayue K | Mathew P Volume: 2011 Issue: default Year: 2011
Available and emerging treatments for Parkinson’s disease: a review
Author(s): Hickey PT | Stacy MA
Volume: 2011
Issue: default
Year: 2011
Author(s): Hickey PT | Stacy MA Volume: 2011 Issue: default Year: 2011
Update on role of agalsidase alfa in management of Fabry disease
Author(s): Uma Ramaswami
Volume: 2011
Issue: default
Year: 2011
Author(s): Uma Ramaswami Volume: 2011 Issue: default Year: 2011
Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
Author(s): Lilliana Oliveira | Russell D Cohen
Volume: 2011
Issue: default
Year: 2011
Author(s): Lilliana Oliveira | Russell D Cohen Volume: 2011 Issue: default Year: 2011
Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan
Author(s): Shinichiro Ryuge | Shi-Xu Jiang | Mayuko Wada | Ken Katono | et al.
Volume: 2009
Issue: default
Year: 2009
Author(s): Shinichiro Ryuge | Shi-Xu Jiang | Mayuko Wada | Ken Katono | et al. Volume: 2009 Issue: default Year: 2009
Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin
Author(s): Michiko Yamamoto | Akira Takakura | Noriyuki Masuda
Volume: 2008
Issue: default
Year: 2008
Author(s): Michiko Yamamoto | Akira Takakura | Noriyuki Masuda Volume: 2008 Issue: default Year: 2008
New anticoagulants for the prevention of venous thromboembolism
Author(s): Cecilia Becattini | Alessandra Lignani | Giancarlo Agnelli
Volume: 2010
Issue: default
Year: 2010
Author(s): Cecilia Becattini | Alessandra Lignani | Giancarlo Agnelli Volume: 2010 Issue: default Year: 2010
Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
Author(s): M Tiseo | M Bartolotti | F Gelsomino | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): M Tiseo | M Bartolotti | F Gelsomino | et al Volume: 2010 Issue: default Year: 2010
ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
Author(s): Aysegul Nalca | Elizabeth E Zumbrun
Volume: 2010
Issue: default
Year: 2010
Author(s): Aysegul Nalca | Elizabeth E Zumbrun Volume: 2010 Issue: default Year: 2010
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
Author(s): Gautam V Ramani | Myung H Park
Volume: 2010
Issue: default
Year: 2010
Author(s): Gautam V Ramani | Myung H Park Volume: 2010 Issue: default Year: 2010
Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations
Author(s): Lucy Cook | Nichola Cooper
Volume: 2010
Issue: default
Year: 2010
Author(s): Lucy Cook | Nichola Cooper Volume: 2010 Issue: default Year: 2010
Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
Author(s): Pär I Johansson | Sisse R Ostrowski
Volume: 2010
Issue: default
Year: 2010
Author(s): Pär I Johansson | Sisse R Ostrowski Volume: 2010 Issue: default Year: 2010
Development of a sublingual allergy vaccine for grass pollinosis
Author(s): Franco Frati | Silvia Scurati | Paola Puccinelli | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Franco Frati | Silvia Scurati | Paola Puccinelli | et al Volume: 2010 Issue: default Year: 2010
Safety and efficacy of azacitidine in myelodysplastic syndromes
Author(s): Carlos E Vigil | Taida Martin-Santos | Guillermo Garcia-Manero
Volume: 2010
Issue: default
Year: 2010
Author(s): Carlos E Vigil | Taida Martin-Santos | Guillermo Garcia-Manero Volume: 2010 Issue: default Year: 2010
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections
Author(s): Emily Zoller | Connie Valente | Kyle Baker | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Emily Zoller | Connie Valente | Kyle Baker | et al Volume: 2010 Issue: default Year: 2010
Silodosin in the treatment of benign prostatic hyperplasia
Author(s): Maxime Rossi | Thierry Roumeguère
Volume: 2010
Issue: default
Year: 2010
Author(s): Maxime Rossi | Thierry Roumeguère Volume: 2010 Issue: default Year: 2010
Corrigendum: Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B
Author(s): Scior T | Guevara-Garcia JA | Melendez FJ | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Scior T | Guevara-Garcia JA | Melendez FJ | et al Volume: 2010 Issue: default Year: 2010
Illicit methylphenidate use among Iranian medical students: prevalence and knowledge
Author(s): Afshin Habibzadeh Mahasti Alizadeh Ayoub Malek | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Afshin Habibzadeh Mahasti Alizadeh Ayoub Malek | et al Volume: 2011 Issue: default Year: 2011
Pleiotropic vasoprotective effects of statins: The chicken or the egg?
Author(s): Dimitrios Kirmizis | Dimitrios Chatzidimitriou
Volume: 2009
Issue: default
Year: 2009
Author(s): Dimitrios Kirmizis | Dimitrios Chatzidimitriou Volume: 2009 Issue: default Year: 2009
Raltegravir in the management of HIV-infected patients
Author(s): Hans-Jürgen Stellbrink
Volume: 2008
Issue: default
Year: 2008
Author(s): Hans-Jürgen Stellbrink Volume: 2008 Issue: default Year: 2008
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors
Author(s): Xuan Huang | Samir Patel | Nasir Ahmed | Karen Seiter | Delong Liu
Volume: 2008
Issue: default
Year: 2008
Author(s): Xuan Huang | Samir Patel | Nasir Ahmed | Karen Seiter | Delong Liu Volume: 2008 Issue: default Year: 2008
New atypical antipsychotics for schizophrenia: iloperidone
Author(s): Silvio Caccia | Luca Pasina | Alessandro Nobili
Volume: 2010
Issue: default
Year: 2010
Author(s): Silvio Caccia | Luca Pasina | Alessandro Nobili Volume: 2010 Issue: default Year: 2010
Continuation treatment of major depressive disorder: is there a case for duloxetine?
Author(s): Trevor R Norman | James S Olver
Volume: 2010
Issue: default
Year: 2010
Author(s): Trevor R Norman | James S Olver Volume: 2010 Issue: default Year: 2010
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal
Author(s): Chaouki K Khoury | James R Couch
Volume: 2010
Issue: default
Year: 2010
Author(s): Chaouki K Khoury | James R Couch Volume: 2010 Issue: default Year: 2010
Recent advances in the treatment of premature ejaculation
Author(s): Kate D Linton | Kevan R Wylie
Volume: 2010
Issue: default
Year: 2010
Author(s): Kate D Linton | Kevan R Wylie Volume: 2010 Issue: default Year: 2010
Current and developing therapeutic agents in the treatment of Chagas disease
Author(s): Werner Apt
Volume: 2010
Issue: default
Year: 2010
Author(s): Werner Apt Volume: 2010 Issue: default Year: 2010
Liraglutide in the management of type 2 diabetes
Author(s): Estela Wajcberg | Amatur Amarah
Volume: 2010
Issue: default
Year: 2010
Author(s): Estela Wajcberg | Amatur Amarah Volume: 2010 Issue: default Year: 2010
New approaches in the management of multiple sclerosis
Author(s): Laurie J Barten | Douglas R Allington | Kendra A Procacci | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Laurie J Barten | Douglas R Allington | Kendra A Procacci | et al Volume: 2010 Issue: default Year: 2010
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
Author(s): Ignacio Garcia-Valladares | Raquel Cuchacovich | Luis R Espinoza
Volume: 2011
Issue: default
Year: 2011
Author(s): Ignacio Garcia-Valladares | Raquel Cuchacovich | Luis R Espinoza Volume: 2011 Issue: default Year: 2011
Corrigendum
Author(s): Channing J Paller | Emmanuel S Antonarakis
Volume: 2011
Issue: default
Year: 2011
Author(s): Channing J Paller | Emmanuel S Antonarakis Volume: 2011 Issue: default Year: 2011
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
Author(s): John Puetz
Volume: 2010
Issue: default
Year: 2010
Author(s): John Puetz Volume: 2010 Issue: default Year: 2010
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
Author(s): Clemens Warnke | Heinz Wiendl | Hans-Peter Hartung | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Clemens Warnke | Heinz Wiendl | Hans-Peter Hartung | et al Volume: 2010 Issue: default Year: 2010
